Percussion Massage Therapy and IASTM in Subacromial Impingement Syndrome (NCT07291843) | Clinical Trial Compass
CompletedNot Applicable
Percussion Massage Therapy and IASTM in Subacromial Impingement Syndrome
Turkey (Türkiye)48 participantsStarted 2025-12-10
Plain-language summary
This assessor-blinded, three-arm, parallel-group randomized controlled trial investigated the additional effects of percussion massage therapy and instrument-assisted soft tissue mobilization in individuals with subacromial impingement syndrome. Forty-eight participants aged 40-60 years with clinically and magnetic resonance imaging-confirmed subacromial impingement syndrome were randomly allocated in a 1:1:1 ratio to conventional physiotherapy, percussion massage therapy plus conventional physiotherapy, or instrument-assisted soft tissue mobilization plus conventional physiotherapy.
All groups received a standardized four-week conventional physiotherapy programme. Participants in the percussion massage therapy and instrument-assisted soft tissue mobilization groups additionally received their respective interventions three times per week for four weeks. Outcomes were evaluated at baseline and immediately after the four-week intervention. The primary outcome was shoulder joint position sense during flexion and abduction. Secondary outcomes were shoulder range of motion, resting and activity-related pain, upper-extremity disability, and rotator cuff-related quality of life.
Who can participate
Age range
40 Years – 60 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Men or women aged 40 to 60 years.
* Diagnosis of subacromial impingement syndrome confirmed by clinical examination and -magnetic resonance imaging.
* Positive Neer test.
* Positive Hawkins-Kennedy test.
* Positive painful arc test.
* Shoulder symptoms persisting for at least one month.
* Ability and willingness to participate in the assessment and intervention programme.
* Provision of written informed consent.
Exclusion Criteria:
* Previous surgery involving the affected upper extremity.
* Inflammatory joint disease.
* Shoulder osteoarthritis.
* Rheumatic disease.
* Malignant or benign tumour affecting the shoulder region or upper extremity.
* Open wound or active infection in the shoulder region.
* Inability to tolerate vibration-based therapy.
* Inability to comply with the study protocol or intervention programme.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in Shoulder Joint Position Sense Error
Timeframe: Baseline and immediately after the 4-week intervention